DRMA

Dermata Therapeutics Inc

• Reuters·16h ago

  Dermata Therapeutics announces annual shareholder meeting webcast

• TipRanks·5d ago

  Dermata receives notice of acceptance of Australian patent application

• Benzinga·5d ago

  Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers

• Reuters·5d ago

  Dermata says Australian patent application for topical dermal fillers accepted for Bioneedle system

• TipRanks·6d ago

  Dermata Therapeutics price target lowered to $4 from $10 at Maxim

• Seeking Alpha·03/27 14:16

  Dermata Therapeutics GAAP EPS of -$8.16

• Reuters·03/26 21:18

  Dermata Therapeutics FY2025 net loss narrows 38.48% to $(7.6) million; operating expenses drop 37.87% to $7.8 million

• Reuters·03/26 21:17

  Dermata Therapeutics FY2025 net loss narrows 38.5% to $7.6 million; cash and cash equivalents climb 138% to $8 million

• Benzinga·03/20 17:06

  12 Health Care Stocks Moving In Friday's Intraday Session

• Benzinga·03/20 14:39

  Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance

• Benzinga·03/20 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• Benzinga·03/20 08:51

  Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

• Benzinga·03/19 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Benzinga·03/19 20:27

  UPDATE: Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"

• Benzinga·03/19 20:00

  Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS"